Open access
Sep 2026
LASSBio-753 as a new prototype of anti-tumor necrosis factor-alpha anti-inflammatory drug.
Pain and inflammation are protective responses; however, when persistent, they can cause damage and reduce the quality of life. The limitations of current therapies underscore the importance of investigating new agents that are effective and have fewer adverse effects. Therefore, the present study aimed to evaluate the...
Tino Marcos Lino da Silva, Viviane Pinheiro Alves de Almeida, A. D. de Sousa et al.
· Biomedicine & pharmacotherap... · 0 citations